These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16397019

  • 1. Activation of stat3 in primary tumors from high-risk breast cancer patients is associated with elevated levels of activated SRC and survivin expression.
    Diaz N, Minton S, Cox C, Bowman T, Gritsko T, Garcia R, Eweis I, Wloch M, Livingston S, Seijo E, Cantor A, Lee JH, Beam CA, Sullivan D, Jove R, Muro-Cacho CA.
    Clin Cancer Res; 2006 Jan 01; 12(1):20-8. PubMed ID: 16397019
    [Abstract] [Full Text] [Related]

  • 2. Persistent activation of stat3 signaling induces survivin gene expression and confers resistance to apoptosis in human breast cancer cells.
    Gritsko T, Williams A, Turkson J, Kaneko S, Bowman T, Huang M, Nam S, Eweis I, Diaz N, Sullivan D, Yoder S, Enkemann S, Eschrich S, Lee JH, Beam CA, Cheng J, Minton S, Muro-Cacho CA, Jove R.
    Clin Cancer Res; 2006 Jan 01; 12(1):11-9. PubMed ID: 16397018
    [Abstract] [Full Text] [Related]

  • 3. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells.
    Asanuma H, Torigoe T, Kamiguchi K, Hirohashi Y, Ohmura T, Hirata K, Sato M, Sato N.
    Cancer Res; 2005 Dec 01; 65(23):11018-25. PubMed ID: 16322251
    [Abstract] [Full Text] [Related]

  • 4. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
    Rosen DG, Mercado-Uribe I, Yang G, Bast RC, Amin HM, Lai R, Liu J.
    Cancer; 2006 Dec 01; 107(11):2730-40. PubMed ID: 17063503
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of potential Stat3-regulated genes in human breast cancer.
    Hsieh FC, Cheng G, Lin J.
    Biochem Biophys Res Commun; 2005 Sep 23; 335(2):292-9. PubMed ID: 16081048
    [Abstract] [Full Text] [Related]

  • 6. STAT3 mRNA and protein expression in colorectal cancer: effects on STAT3-inducible targets linked to cell survival and proliferation.
    Lassmann S, Schuster I, Walch A, Göbel H, Jütting U, Makowiec F, Hopt U, Werner M.
    J Clin Pathol; 2007 Feb 23; 60(2):173-9. PubMed ID: 17264243
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors.
    Karni R, Jove R, Levitzki A.
    Oncogene; 1999 Aug 19; 18(33):4654-62. PubMed ID: 10467412
    [Abstract] [Full Text] [Related]

  • 8. Coordinate expression of apoptosis-associated proteins in human breast cancer before and during chemotherapy.
    Parton M, Krajewski S, Smith I, Krajewska M, Archer C, Naito M, Ahern R, Reed J, Dowsett M.
    Clin Cancer Res; 2002 Jul 19; 8(7):2100-8. PubMed ID: 12114409
    [Abstract] [Full Text] [Related]

  • 9. Resistance to chemotherapy via Stat3-dependent overexpression of Bcl-2 in metastatic breast cancer cells.
    Real PJ, Sierra A, De Juan A, Segovia JC, Lopez-Vega JM, Fernandez-Luna JL.
    Oncogene; 2002 Oct 31; 21(50):7611-8. PubMed ID: 12400004
    [Abstract] [Full Text] [Related]

  • 10. Predictive biological markers for response of invasive breast cancer to anthracycline/cyclophosphamide-based primary (radio-)chemotherapy.
    Prisack HB, Karreman C, Modlich O, Audretsch W, Danae M, Rezai M, Bojar H.
    Anticancer Res; 2005 Oct 31; 25(6C):4615-21. PubMed ID: 16334152
    [Abstract] [Full Text] [Related]

  • 11. Stat3 activation in human endometrial and cervical cancers.
    Chen CL, Hsieh FC, Lieblein JC, Brown J, Chan C, Wallace JA, Cheng G, Hall BM, Lin J.
    Br J Cancer; 2007 Feb 26; 96(4):591-9. PubMed ID: 17311011
    [Abstract] [Full Text] [Related]

  • 12. Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers.
    Sharma H, Sen S, Mathur M, Bahadur S, Singh N.
    Head Neck; 2004 Aug 26; 26(8):733-40. PubMed ID: 15287041
    [Abstract] [Full Text] [Related]

  • 13. Cytoplasmic poly(adenosine diphosphate-ribose) polymerase expression is predictive and prognostic in patients with breast cancer treated with neoadjuvant chemotherapy.
    von Minckwitz G, Müller BM, Loibl S, Budczies J, Hanusch C, Darb-Esfahani S, Hilfrich J, Weiss E, Huober J, Blohmer JU, du Bois A, Zahm DM, Khandan F, Hoffmann G, Gerber B, Eidtmann H, Fend F, Dietel M, Mehta K, Denkert C.
    J Clin Oncol; 2011 Jun 01; 29(16):2150-7. PubMed ID: 21519019
    [Abstract] [Full Text] [Related]

  • 14. The nuclear transcription factor kappaB/bcl-2 pathway correlates with pathologic complete response to doxorubicin-based neoadjuvant chemotherapy in human breast cancer.
    Buchholz TA, Garg AK, Chakravarti N, Aggarwal BB, Esteva FJ, Kuerer HM, Singletary SE, Hortobagyi GN, Pusztai L, Cristofanilli M, Sahin AA.
    Clin Cancer Res; 2005 Dec 01; 11(23):8398-402. PubMed ID: 16322301
    [Abstract] [Full Text] [Related]

  • 15. EGFR, HER2, survivin, and loss of pSTAT3 characterize high-grade malignancy in salivary gland cancer with impact on prognosis.
    Ettl T, Stiegler C, Zeitler K, Agaimy A, Zenk J, Reichert TE, Gosau M, Kühnel T, Brockhoff G, Schwarz S.
    Hum Pathol; 2012 Jun 01; 43(6):921-31. PubMed ID: 22154363
    [Abstract] [Full Text] [Related]

  • 16. Comparison of extracellular matrix and apoptotic markers between benign lesions and carcinomas in human breast.
    Vasaturo F, Sallusti E, Gradilone A, Malacrino C, Nardo T, Avagnano G, Aglianò AM, Granato T, De Vincenzi B, Coppotelli G, Marzullo A, Soda G, Simonelli L, Modesti M, Scarpa S.
    Int J Oncol; 2005 Oct 01; 27(4):1005-11. PubMed ID: 16142317
    [Abstract] [Full Text] [Related]

  • 17. Cyclin D1 overexpression and response to bortezomib treatment in a breast cancer model.
    Ishii Y, Pirkmaier A, Alvarez JV, Frank DA, Keselman I, Logothetis D, Mandeli J, O'Connell MJ, Waxman S, Germain D.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1238-47. PubMed ID: 16954476
    [Abstract] [Full Text] [Related]

  • 18. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F, Núñez-Villar MJ, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2003 Sep 06; 23(1B):565-8. PubMed ID: 12680147
    [Abstract] [Full Text] [Related]

  • 19. Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.
    Rennstam K, McMichael N, Berglund P, Honeth G, Hegardt C, Rydén L, Luts L, Bendahl PO, Hedenfalk I.
    Breast Cancer Res Treat; 2010 Jul 06; 122(2):315-24. PubMed ID: 19795205
    [Abstract] [Full Text] [Related]

  • 20. Survivin as a predictive biomarker of complete pathologic response to neoadjuvant chemotherapy in patients with stage II and stage III breast cancer.
    Petrarca CR, Brunetto AT, Duval V, Brondani A, Carvalho GP, Garicochea B.
    Clin Breast Cancer; 2011 Apr 06; 11(2):129-34. PubMed ID: 21569999
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.